AUG 10, 2026 · PHASE 2 TRIAL
Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer
ClinicalTrials.gov
Phase 2 trial in recruitment with no results posted; study design and patient population are defined but outcomes remain unreported.
Reported
Estimated enrollment86
Primary endpointProgression-free survival (PFS) from initia…
PhasePhase 2